113 related articles for article (PubMed ID: 29996970)
1. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
Xue R; Cai X; Xu H; Wu S; Huang H
Gynecol Oncol; 2018 Sep; 150(3):412-419. PubMed ID: 29996970
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin-based chemoradiotherapy in advanced cervical cancer: an alternative to cisplatin-based regimen?
Sebastião AM; da Silva Rocha LS; Gimenez RD; de Barros LA; Fukushima JT; da Silva SC; da Costa Miranda V; de Souza Caires IQ; de Freitas D; Filho EA; Diz Mdel P
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():161-5. PubMed ID: 27137353
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
4. Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
Tharavichitkul E; Lorvidhaya V; Kamnerdsupaphon P; Sukthomya V; Chakrabandhu S; Klunklin P; Onchan W; Supawongwattana B; Pukanhaphan N; Galalae R; Chitapanarux I
BMC Cancer; 2016 Jul; 16():501. PubMed ID: 27435245
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis.
Petrelli F; De Stefani A; Raspagliesi F; Lorusso D; Barni S
Gynecol Oncol; 2014 Jul; 134(1):166-71. PubMed ID: 24793000
[TBL] [Abstract][Full Text] [Related]
6. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
7. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of concurrent radiotherapy and weekly paclitaxel/carboplatin therapy in cervical cancer: a retrospective study.
Chikazawa K; Netsu S; Konno R
Eur J Gynaecol Oncol; 2016 Aug; 37(4):511-516. PubMed ID: 29894076
[TBL] [Abstract][Full Text] [Related]
9. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
[TBL] [Abstract][Full Text] [Related]
10. Radiation with cisplatin or carboplatin for locally advanced cervix cancer: the experience of a tertiary cancer centre.
Au-Yeung G; Mileshkin L; Bernshaw DM; Kondalsamy-Chennakesavan S; Rischin D; Narayan K
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):97-104. PubMed ID: 23374561
[TBL] [Abstract][Full Text] [Related]
11. Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer.
Takeshita S; Kita T; Motoike Y; Umezawa K; Sugisaki S; Matsumoto S; Matsumoto Y; Ryo E; Ayabe T
J Obstet Gynaecol Res; 2010 Oct; 36(5):1009-14. PubMed ID: 20722988
[TBL] [Abstract][Full Text] [Related]
12. Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy.
Braicu EI; Fotopoulou C; Chekerov R; Richter R; Blohmer J; Kümmel S; Stamatian F; Yalcinkaya I; Mentze M; Lichtenegger W; Sehouli J
Cytokine; 2013 Mar; 61(3):755-8. PubMed ID: 23415672
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of neoadjuvant chemotherapy-related strategies compared with concurrent chemoradiotherapy for locally advanced cervical cancer: a meta-analysis of randomized controlled trials.
Wang B; Tan Y; Yang X; Man X
Arch Gynecol Obstet; 2021 Aug; 304(2):485-493. PubMed ID: 33389099
[TBL] [Abstract][Full Text] [Related]
14. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
16. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
[TBL] [Abstract][Full Text] [Related]
18. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis result.
Hu Y; Cai ZQ; Su XY
Asian Pac J Cancer Prev; 2012; 13(9):4301-4. PubMed ID: 23167332
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of concurrent chemoradiotherapy with weekly carboplatin in locally-advanced carcinoma of the uterine cervix patients.
Sangkittipaiboon S
J Med Assoc Thai; 2014 Jan; 97(1):12-9. PubMed ID: 24701724
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
